Investment Trusts

Worldwide Healthcare

WWH:LSE

Worldwide Healthcare

Actions
  • Price (GBX)327.00
  • Today's Change4.00 / 1.24%
  • Shares traded934.11k
  • 1 Year change+10.47%
  • Beta0.3901
Data delayed at least 20 minutes, as of Nov 21 2024 16:36 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Total returns on £1000

1Y
Fund/benchmarkChange
PriceWorldwide Healthcare (Ordinary Share)+10.16%
NAVWorldwide Healthcare (Ordinary Share)+12.19%
Morningstar's BenchmarkMSCI World Health Care GR--

Key statistics

On Thursday, Worldwide Healthcare (WWH:LSE) closed at 327.00, 11.79% above the 52 week low of 292.50 set on Nov 30, 2023.
52-week range
Today
292.50Nov 30 2023372.50Jul 17 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Shares outstanding512.56m
Market cap1.66bn GBP
Total assets1.94bn GBP
Total expense ratio0.86%
High327.00
Low322.50
Previous close323.00
Average volume1.11m
YTD Change+5.14%
Beta0.3901
Diluted NAV (est)371.91
Diluted NAV (last pub)366.64
Premium/Discount-13.15%
Net Gearing0.00%
Annual div (ADY)2.80
GBX
Annual div yield (ADY)0.87%
Div ex-dateJun 13 2024
Div pay-dateJul 24 2024
Next div ex-dateNov 28 2024
Next div pay-dateJan 09 2025
Data delayed at least 20 minutes, as of Nov 21 2024 16:36 GMT.
More ▼

Board of Directors

1/7

Doug McCutcheon, Chairman

2/7

Sven H. Borho

3/7

Dr Bandhana (Bina) Rawal

4/7

Tim Livett

5/7

Joanne Parfrey

6/7

Sian Hansen

7/7

William Hemmings

Contact

Registered Office:
One Wood Street
London
EC2V 7WS

Alternative Investment Fund Manager, Company Secretary and Administrator
Frostrow Capital LLP
25 Southampton Buildings
London
WC2A 1AL

T: 0203 008 4910
E: info@frostrow.com
W: www.frostrow.com
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.